Freeze-dried haemophilus influenzae type B combined vaccine (Beijing Zhifei Lvzhu Biopharmaceutical)

冻干b型流感嗜血杆菌结合疫苗 (北京智飞绿竹生物制药有限公司)

Report date: 2024/05/30 18:03:04

Base Information

Drug NameFreeze-dried haemophilus influenzae type B combined vaccine (Beijing Zhifei Lvzhu Biopharmaceutical)
Drug Alias NameHaemophilus influenzae type B combined vaccine (Beijing Zhifei Lvzhu Biopharmaceutical)Lyophilized Haemophilus influenzae type B combined vaccine (Beijing Zhifei Lvzhu Biopharmaceutical)
ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHaemophilus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesBeijing Zhifei Lvzhu Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHebei Provincial Center For Disease Control And PreventionBeijing Zhifei Lvzhu Biopharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHaemophilus Infections

Other Information

ATC CodeN/A
Related LinksN/A